Omada Health (NASDAQ:OMDA) CFO Sells $378,206.50 in Stock

by · The Markets Daily

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CFO Steven Cook sold 17,950 shares of the firm’s stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $21.07, for a total transaction of $378,206.50. Following the completion of the transaction, the chief financial officer directly owned 115,409 shares in the company, valued at $2,431,667.63. This represents a 13.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Omada Health Price Performance

OMDA stock traded up $0.28 during trading on Tuesday, hitting $21.95. The stock had a trading volume of 853,685 shares, compared to its average volume of 1,070,637. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The company’s 50-day moving average price is $16.83 and its two-hundred day moving average price is $14.93. The stock has a market capitalization of $1.30 billion and a P/E ratio of -81.30.

Omada Health (NASDAQ:OMDA – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, sell-side analysts expect that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

OMDA has been the topic of a number of research reports. JPMorgan Chase & Co. decreased their price objective on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a report on Thursday, March 12th. BMO Capital Markets dropped their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, March 6th. Citizens Jmp increased their target price on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research report on Friday, May 8th. Weiss Ratings raised shares of Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday. Finally, The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Omada Health has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Read Our Latest Analysis on Omada Health

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of OMDA. Bank of America Corp DE raised its holdings in shares of Omada Health by 51.5% during the 1st quarter. Bank of America Corp DE now owns 161,099 shares of the company’s stock worth $2,025,000 after acquiring an additional 54,792 shares during the period. Stoic Point Capital Management LLC purchased a new stake in shares of Omada Health in the first quarter valued at about $1,830,000. Quantinno Capital Management LP increased its position in Omada Health by 464.1% during the first quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock worth $738,000 after purchasing an additional 48,313 shares during the last quarter. Entropy Technologies LP purchased a new position in Omada Health during the first quarter worth about $194,000. Finally, Renaissance Technologies LLC raised its stake in Omada Health by 173.9% during the first quarter. Renaissance Technologies LLC now owns 391,069 shares of the company’s stock worth $4,916,000 after purchasing an additional 248,269 shares during the period.

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Recommended Stories